![4-[(1-Pyrrolidinylsulfonyl)methyl]aniline CAS 334981-10-1 Pite> 99.0% (HPLC) Almotriptan Aniline Precursor Faktori Prezantasyon Imaj](https://www.ruifuchemical.com/uploads/4-1-Pyrrolidinylsulfonylmethylaniline-CAS-334981-10-1-Purity-99.0-HPLC-Almotriptan-Intermediate-Factory.jpg)
4-[(1-Pyrrolidinylsulfonyl)methyl]aniline CAS 334981-10-1 Pite> 99.0% (HPLC) Almotriptan anilin Precursor faktori
Ruifu Chemical Supply Almotriptan Malate Entèmedyè:
Almotriptan Malate CAS 181183-52-8
1-((4-Hydrazinylbenzyl)sulfonyl)pyrrolidine Hydrochloride CAS 334981-11-2
4-[(1-Pyrrolidinylsulfonyl)methyl]aniline CAS 334981-10-1
1-[(4-Nitrophenylmethyl)sulfonyl]pyrrolidine CAS 340041-91-0
4-Chlorobutyraldehyde Diethyl Acetal CAS 6139-83-9
| Non Chimik | 4-[(1-Pyrrolidinylsulfonyl)methyl]anilin |
| Sinonim | 1-[(4-Aminobenzyl)sulfonyl]pirolidin;Almotriptan anilin précurseur |
| Nimewo CAS | 334981-10-1 |
| Nimewo CAT | RF-PI1948 |
| Estati Stock | Nan Stock, Pwodiksyon Echèl Jiska Tòn |
| Fòmil molekilè | C11H16N2O2S |
| Pwa molekilè | 240.32 |
| Pwen k ap fonn | 170.0 a 176.0 ℃ |
| Dansite | 1.31 |
| Solibilite | Yon ti kras soluble nan toluèn |
| Mak | Ruifu Chimik |
| Atik | Espesifikasyon |
| Aparans | Poud cristalline blan pou endispoze jòn |
| Pite / Metòd analiz | >99.0% (HPLC) |
| Pèt sou siye | <0.50% |
| Rezid sou ignisyon | <0.50% |
| Max Single enpurte | <0.50% |
| Enpurte total | <1.00% |
| Metal lou | <20ppm |
| Enfrawouj Spectrum | Konfòm ak estrikti |
| RMN | Konfòm ak estrikti |
| Tès Creole | Enterprise Standard |
| Itilizasyon | Almotriptan anilin précurseur |
Pake: Boutèy, sak papye aliminyòm, 25kg / tanbou katon, oswa selon kondisyon kliyan an
Kondisyon Depo:Sere nan resipyan ki fèmen nan yon kote ki fre ak sèk;Pwoteje kont limyè ak imidite
4-[(1-Pyrrolidinylsulfonyl)methyl]aniline (CAS: 334981-10-1) se yon entèmedyè nan preparasyon Almotriptan Malate (CAS: 181183-52-8), Almotriptan anilin précurseur.Almotriptan Malate se yon kalite dwòg triptan ki ka itilize pou tretman maltèt migrèn.Almotriptan se fè pati yon kategori dwòg nan agonist reseptè serotonin selektif.Almotriptan gen yon afinite segondè ak espesifik pou reseptè serotonin 5-HT, plis ki mennen nan vascoconstriction nan veso sangen nan sèvo ak afekte redistribisyon sikilasyon san an.Efè sa yo sispann siyal doulè yo te voye nan sèvo a, ak plis siprime liberasyon an nan sèten sibstans natirèl ki lakòz doulè, kè plen ak lòt sentòm migrèn.Sepandan, Almotriptan pa anpeche atak migrèn.Almotriptan, ki te commercialisés an 2000, gen pi gwo biodisponibilite oral nan mitan tout triptan yo.Almotriptan metabolize pa tou de MAO-A ak CYP3A4, kidonk gen yon pwofil efè segondè pi favorab lè yo konpare ak Sumatriptan.
![4-[(1-Pyrrolidinylsulfonyl)methyl]aniline CAS 334981-10-1 Pite> 99.0% (HPLC) Almotriptan anilin Precursor faktori](https://www.ruifuchemical.com/uploads/4-1-Pyrrolidinylsulfonylmethylaniline-CAS-334981-10-1-Purity-99.0-HPLC-Almotriptan-Intermediate-Factory-300x300.jpg)
![1-[(4-Nitrophenylmethyl)sulfonyl]pyrrolidine CAS 340041-91-0 Pite> 98.0% (HPLC) Almotriptan Malate Faktori Entèmedyè](https://www.ruifuchemical.com/uploads/1-4-Nitrophenylmethylsulfonylpyrrolidine-CAS-340041-91-0-Purity-99.0-HPLC-Almotriptan-Intermediate-Factory-300x300.png)
